BioSig Technologies, Inc. is a medical device company that operates through its subsidiaries. Its flagship product PURE EP system provides precise and real-time evaluation of electrograms electrophysiology to facilitate diagnosis challenges and provide intracardiac signal acquisition. The company also has research agreements with the University of Minnesota for novel therapies to treat nervous system diseases and a strategic collaboration with the Mayo Foundation to develop AI-based software solutions.